The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative Experience EDITORIAL COMMENT REPLY

被引：0
|
作者：
Morash, Chris [1 ]
机构：
[1] Univ Ottawa, Div Urol, Ottawa, ON, Canada
来源：
JOURNAL OF UROLOGY | 2023年 / 209卷 / 01期
关键词：
D O I：
10.1097/JU.0000000000003012.02
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：179 / 179
页数：1
相关论文
共 16 条
  • [1] The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative Experience
    Paudel, Roshan
    Madan, Raghav
    Qi, Ji
    Ferrante, Stephanie
    Cher, Michael L.
    Lane, Brian R.
    George, Arvin K.
    Semerjian, Alice
    Ginsburg, Kevin B.
    [J]. JOURNAL OF UROLOGY, 2023, 209 (01): : 170 - 178
  • [2] The Use and Short-term Outcomes of Active Surveillance in Men With National Comprehensive Cancer Network Favorable Intermediate-risk Prostate Cancer: The Initial Michigan Urological Surgery Improvement Collaborative Experience Reply by Authors
    Lai, H. Henry
    Wiseman, Jonathan B.
    Helmuth, Margaret E.
    Smith, Abigail R.
    Amundsen, Cindy L.
    Cameron, Anne P.
    Glaser, Alexander P.
    Hendrickson, Whitney K.
    Kirkali, Ziya
    Kenton, Kimberly
    [J]. JOURNAL OF UROLOGY, 2023, 209 (01): : 242 - 242
  • [3] National Comprehensive Cancer Network® Favorable Intermediate Risk Prostate Cancer-Is Active Surveillance Appropriate?
    Aghazadeh, Monty A.
    Frankel, Jason
    Belanger, Matthew
    McLaughlin, Tara
    Tortora, Joseph
    Staff, Ilene
    Wagner, Joseph R.
    [J]. JOURNAL OF UROLOGY, 2018, 199 (05): : 1196 - 1201
  • [4] THE USE AND OUTCOMES OF MEN WITH NCCN FAVORABLE INTERMEDIATE RISK PROSTATE CANCER MANAGED WITH ACTIVE SURVEILLANCE
    Paudel, Roshan
    Madan, Raghav
    Qi, Ji
    Cher, Michael
    Lane, Brian
    George, Arvin
    Semerjian, Alice
    Ginsburg, Kevin
    [J]. JOURNAL OF UROLOGY, 2022, 207 (05): : E745 - E745
  • [5] Active Surveillance for Intermediate Risk Prostate Cancer: Survival Outcomes in the Sunnybrook Experience EDITORIAL COMMENT
    Tosoian, Jeffrey J.
    Alam, Ridwan
    Carter, H. Ballentine
    [J]. JOURNAL OF UROLOGY, 2016, 196 (06): : 1658 - 1658
  • [6] Re: Contemporary Use of Initial Active Surveillance among Men in Michigan with Low-Risk Prostate Cancer Editorial Comment
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2015, 193 (01): : 128 - 129
  • [7] Editorial Comment to "A national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer"
    Matsumoto, Ryuji
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (03) : 297 - 297
  • [8] Editorial Comment on a national questionnaire survey of Japanese urologists on active surveillance for low- and intermediate-risk prostate cancer
    Kishida, Takeshi
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (03) : 298 - 298
  • [9] Short-Term Outcomes of Active Surveillance for Low Risk Prostate Cancer among Men with Germline DNA Repair Gene Mutations EDITORIAL COMMENT
    Barbieri, Christopher E.
    [J]. JOURNAL OF UROLOGY, 2020, 204 (04): : 712 - 713
  • [10] Outcomes of Active Surveillance for Men With Intermediate Risk Prostate Cancer: A Population-Based Analysis EDITORIAL COMMENT
    Whitson, Jared
    [J]. UROLOGY, 2021, 155 : 108 - 109
12